Condition: Misoprostol · Respiratory Distress Syndrome (RDS) of Neonate · Caesarean Section · Sponsor: Kafrelsheikh University
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
This description comes directly from the study's public registry record.
Merna Ashraf Ahmed farid, M.B.B.C.H · 01093030236 · mernaashraf2551996@gmail.com
Always discuss trial participation with your own doctor first.
| Kafr El-sheikh University Hospital | Kafr Ash Shaykh, Egypt, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06946914